File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology

TitleConsensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology
Authors
Keywordsconsensus
Hong Kong
localized prostate cancer
male
#PCSM
Issue Date2018
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/
Citation
BJU International, 2018, v. 124 n. 2, p. 221-241 How to Cite?
AbstractObjective: To formulate consensus statements to facilitate physician management strategies for patients with clinically localized prostate cancer (PCa) in Hong Kong by jointly convening a panel of 12 experts from the two local professional organizations representing PCa specialists, who had previously established consensus statements on the management of metastatic PCa for the locality. Methods: Through a series of meetings, the panellists discussed their clinical experience and the published evidence regarding various areas of the management of localized PCa, then drafted consensus statements. At the final meeting, each drafted statement was voted on by every panellist based on its practicability of recommendation in the locality. Results: A total of 76 consensus statements were ultimately accepted and established by panel voting. Conclusion: Derived from the recent evidence and major overseas guidelines, along with local clinical experience and practicability, the consensus statements were aimed to serve as a practical reference for physicians in Hong Kong for the management of localized PCa.
Persistent Identifierhttp://hdl.handle.net/10722/272987
ISSN
2023 Impact Factor: 3.7
2023 SCImago Journal Rankings: 1.337
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMa, WK-
dc.contributor.authorPoon, DMC-
dc.contributor.authorChan, CK-
dc.contributor.authorChan, TW-
dc.contributor.authorCheung, FY-
dc.contributor.authorHo, LY-
dc.contributor.authorLee, EKC-
dc.contributor.authorLeung, AKC-
dc.contributor.authorLeung, SYL-
dc.contributor.authorSo, HS-
dc.contributor.authorTam, PC-
dc.contributor.authorKwong, PWK-
dc.date.accessioned2019-08-06T09:20:28Z-
dc.date.available2019-08-06T09:20:28Z-
dc.date.issued2018-
dc.identifier.citationBJU International, 2018, v. 124 n. 2, p. 221-241-
dc.identifier.issn1464-4096-
dc.identifier.urihttp://hdl.handle.net/10722/272987-
dc.description.abstractObjective: To formulate consensus statements to facilitate physician management strategies for patients with clinically localized prostate cancer (PCa) in Hong Kong by jointly convening a panel of 12 experts from the two local professional organizations representing PCa specialists, who had previously established consensus statements on the management of metastatic PCa for the locality. Methods: Through a series of meetings, the panellists discussed their clinical experience and the published evidence regarding various areas of the management of localized PCa, then drafted consensus statements. At the final meeting, each drafted statement was voted on by every panellist based on its practicability of recommendation in the locality. Results: A total of 76 consensus statements were ultimately accepted and established by panel voting. Conclusion: Derived from the recent evidence and major overseas guidelines, along with local clinical experience and practicability, the consensus statements were aimed to serve as a practical reference for physicians in Hong Kong for the management of localized PCa.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/-
dc.relation.ispartofBJU International-
dc.rightsThis is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectconsensus-
dc.subjectHong Kong-
dc.subjectlocalized prostate cancer-
dc.subjectmale-
dc.subject#PCSM-
dc.titleConsensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology-
dc.typeArticle-
dc.identifier.emailMa, WK: mwk054@HKUCC-COM.hku.hk-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1111/bju.14681-
dc.identifier.pmid30653801-
dc.identifier.scopuseid_2-s2.0-85061025235-
dc.identifier.hkuros300048-
dc.identifier.volume124-
dc.identifier.issue2-
dc.identifier.spage221-
dc.identifier.epage241-
dc.identifier.isiWOS:000481428300011-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1464-4096-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats